- 全部删除
您的购物车当前为空
Topoisomerase II inhibitor 13抑制拓扑异构酶II (Topo II),对HL-60衍生的HL-60/MX2癌细胞具有较强的抗Topo II 毒性的抗增殖活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Topoisomerase II inhibitor 13抑制拓扑异构酶II (Topo II),对HL-60衍生的HL-60/MX2癌细胞具有较强的抗Topo II 毒性的抗增殖活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 138 | In stock | |
| 5 mg | ¥ 345 | In stock | |
| 10 mg | ¥ 553 | In stock | |
| 25 mg | ¥ 931 | In stock | |
| 50 mg | ¥ 1,390 | In stock | |
| 100 mg | ¥ 2,000 | In stock | |
| 200 mg | ¥ 2,750 | In stock |
Topoisomerase II inhibitor 13 相关产品
| 产品描述 | Topoisomerase II inhibitor 13 inhibits topoisomerase II (Topo II) that shows strong anti-proliferation activity against HL-60/MX2 cancer cells derived from HL-60 against Topo II toxicity. |
| 分子量 | 413.48 |
| 分子式 | C22H23N9 |
| CAS No. | 451515-89-2 |
| Smiles | NC1=C(C=2C(N1CCCN(CC)CC)=NC(C#N)=C(C#N)N2)C=3NC=4C(N3)=CC=CC4 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 6 mg/mL (14.51 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容